scholarly article | Q13442814 |
P50 | author | Peter Bach | Q7172626 |
Michael J Zelefsky | Q51936867 | ||
Elena B Elkin | Q115151505 | ||
P2093 | author name string | Peter T Scardino | |
Colin B Begg | |||
Deborah Schrag | |||
Justin E Bekelman | |||
Ethan M Basch | |||
Thomas L Jang | |||
Yihai Liu | |||
P2860 | cites work | Cancer statistics, 2009 | Q29547625 |
Development of a comorbidity index using physician claims data | Q30623996 | ||
Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement | Q30714854 | ||
Radical prostatectomy versus watchful waiting in early prostate cancer | Q34418166 | ||
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer | Q36433781 | ||
Assessing quality using administrative data | Q36893036 | ||
The Effect of Clustering of Outcomes on the Association of Procedure Volume and Surgical Outcomes | Q47433316 | ||
Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists | Q47801816 | ||
Potential for cancer related health services research using a linked Medicare-tumor registry database. | Q50125205 | ||
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. | Q55067996 | ||
How expert physicians would wish to be treated if they had genitourinary cancer | Q58876886 | ||
Accuracy of diagnostic coding for Medicare patients under the prospective-payment system | Q70374986 | ||
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer | Q73924100 | ||
Variations in morbidity after radical prostatectomy | Q77924924 | ||
United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region | Q78390337 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 440-450 | |
P577 | publication date | 2010-03-01 | |
P1433 | published in | JAMA Internal Medicine | Q177428 |
P1476 | title | Physician visits prior to treatment for clinically localized prostate cancer | |
P478 | volume | 170 |
Q57128167 | Q57128167 |
Q28652628 | A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer |
Q91328899 | Castration remains despite decreasing definitive treatment of localized prostate cancer in the elderly: A case for de-implementation |
Q39591491 | Clinical profile, quality of care, and recurrence in Arab-American and Caucasians prostate cancer patients in Michigan |
Q87587279 | Comment on 'Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer' |
Q87992507 | Comparative Analysis of the Views of Oncologic Subspecialists and Palliative/Supportive Care Physicians Regarding Advanced Care Planning and End-of-Life Care |
Q91725984 | Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer |
Q51248430 | Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study. |
Q35577609 | Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis |
Q46259067 | Decision-making processes among men with low-risk prostate cancer: A survey study |
Q57835104 | Dental care providers' decision making regarding maintenance of compromised teeth and implant therapy indication: an analysis of gender and enrollment in teaching positions |
Q36823071 | Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program |
Q87019072 | Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey |
Q35114920 | Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population |
Q95503798 | Editorial comment |
Q90557517 | Empowering patients in decision-making in radiation oncology - can we do better? |
Q34335177 | Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. |
Q36522791 | Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer |
Q89496416 | Exposure to radiation and medical oncology training: A survey of Canadian urology residents and fellows |
Q42669921 | Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia. |
Q55312114 | Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database. |
Q93349353 | Factors underlying treatment decision-making for localized prostate cancer in the U.S. and Canada: A scoping review using principal component analysis |
Q64066683 | Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence |
Q35602510 | Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse |
Q36776998 | Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications |
Q35869811 | High-risk prostate cancer-classification and therapy |
Q30417174 | Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications |
Q34679220 | Impact of age at diagnosis on prostate cancer treatment and survival |
Q36520523 | Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions |
Q49987316 | Incongruence in treatment decision making is associated with lower health-related quality of life among prostate cancer survivors: results from the PiCTure study |
Q39400229 | Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study |
Q41141658 | Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer |
Q36222876 | Influence of primary care on breast cancer outcomes among Medicare beneficiaries |
Q41814411 | Information needs of early-stage prostate cancer patients: within- and between-group agreement of patients and health professionals |
Q41737229 | Interdisciplinary counseling service for renal malignancies: a patient-centered approach to raise guideline adherence |
Q35459197 | Locoregional prostate cancer treatment pattern variation in independent cancer centers: policy effect, patient preference, or physician incentive? |
Q45538851 | Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-up |
Q40732738 | Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer |
Q24235544 | Low-dose rate brachytherapy for men with localized prostate cancer |
Q41645248 | Multidisciplinary Oncology Education: Going Beyond Tumor Board. |
Q47179230 | Out of the Basement and Into the Classroom: Pathways for Expanding the Role of Radiation Oncologists in Medical Student Education. |
Q34696349 | Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer |
Q57169399 | Overdiagnosis in primary care: framing the problem and finding solutions |
Q46627682 | Patient Decision Making Prior to Radical Prostatectomy: What Is and Is Not Involved |
Q85225385 | Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions |
Q84467389 | Patients and solipsism: the psychology of decision making for prostate cancer treatment |
Q36905270 | Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer |
Q39023568 | Perineal discomfort in prostatic adenocarcinoma |
Q88560388 | Physician visits and the timing of skeletal-related events among men newly diagnosed with metastatic prostate cancer: A cohort analysis |
Q44898794 | Population-based comparative effectiveness of salvage radical prostatectomy vs cryotherapy |
Q43978055 | Preferences of dental care providers in maintaining compromised teeth in relation to their professional status: implants instead of periodontally involved maxillary molars? |
Q39776492 | Prostate Cancer Care Before and After Medicare Eligibility. |
Q85421133 | Prostate cancer: challenges in selecting the optimal therapy |
Q31138079 | Provider continuity prior to the diagnosis of advanced lung cancer and end-of-life care |
Q35819651 | Racial disparities in changing to a high-volume urologist among men with localized prostate cancer |
Q38432682 | Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: Comparison of treatment outcomes |
Q35743202 | Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer |
Q48194820 | Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer |
Q36534788 | Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer |
Q36520534 | Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer |
Q88548478 | Role of collaboration between urologists and medical oncologists in the advanced prostate cancer space |
Q35705334 | Shared decision making in oncology practice: what do oncologists need to know? |
Q38775761 | Specialist visits and initiation of cancer-directed treatment among a large cohort of men diagnosed with prostate cancer. |
Q48085035 | Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer |
Q55215370 | Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis. |
Q33946732 | Surgical quality is more than volume: the association between changing urologists and complications for patients with localized prostate cancer |
Q50958640 | The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes. |
Q39620429 | The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer. |
Q47900716 | The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments. |
Q53277349 | The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation. |
Q38414986 | The impact of county-level radiation oncologist density on prostate cancer mortality in the United States |
Q36290824 | The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience |
Q42265374 | Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer |
Q48250064 | Trust versus paternalism |
Q53168767 | Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis. |
Q38019954 | Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC). |
Q92100760 | Validation of an Algorithm for Claims-based Incidence of Prostate Cancer |
Q40967147 | Variation in prostate cancer treatment associated with population density of the county of residence |
Q87187663 | Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty |
Q40209684 | When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment |
Q38366517 | Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer. |
Q53199712 | [Decision aids for patients are widely accepted by German urologists : A survey among members of the German Society of Urology (DGU) and the Federation of German Urologists (BDU)]. |
Search more.